CompletedNot Applicable

PCT of Pharmacopuncture for Chronic Neck Pain

South Korea128 participantsStarted 2024-09-11

Plain-language summary

A pragmatic clinical study to compare the effectiveness of pharmacopuncture and acupuncture treatment strategies in patients with chronic neck pain

Age range19 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Patients with neck pain persisting for more than 3 months
✓. Patients with a Numeric Rating Scale (NRS) score of 5 or higher for neck pain
✓. Patients aged between 19 and 70 years
✓. Patients who agree to participate in the clinical study and provide a written informed consent form

✕. Patients diagnosed with serious specific diseases that could be the cause of neck pain (e.g., spinal metastasis of tumors, acute fractures, and spinal dislocations)
✕. Patients exhibiting progressive neurological deficits or severe neurological symptoms
✕. Patients whose pain originates from soft tissue disorders rather than the spine (e.g., tumors, fibromyalgia, rheumatoid arthritis, gout)
✕. Patients with other chronic diseases that could interfere with the interpretation of treatment effects or outcomes (e.g., stroke, myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy)
✕. Patients currently taking steroids, immunosuppressants, psychiatric medications, or other drugs that could affect the study results
✕. Patients for whom pharmacopuncture treatment is inappropriate or unsafe: those with bleeding disorders, those undergoing anticoagulant therapy, and severe diabetic patients with infection risks
✕. Patients who have taken medications that could affect pain (e.g., Non-Steroidal Anti-Inflammatory Drugs, NSAIDs) or received pharmacopuncture, acupuncture, or physical therapy within the past week
✕. Pregnant women, those planning to become pregnant, or those currently breastfeeding

Neck pain Numeric Rating Scale, NRS

Timeframe: Week 5

NCT IDNCT06520462

SponsorJaseng Medical Foundation

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04-04

Who can participate

Age range19 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Patients with neck pain persisting for more than 3 months
✓. Patients with a Numeric Rating Scale (NRS) score of 5 or higher for neck pain
✓. Patients aged between 19 and 70 years
✓. Patients who agree to participate in the clinical study and provide a written informed consent form

✕. Patients diagnosed with serious specific diseases that could be the cause of neck pain (e.g., spinal metastasis of tumors, acute fractures, and spinal dislocations)
✕. Patients exhibiting progressive neurological deficits or severe neurological symptoms
✕. Patients whose pain originates from soft tissue disorders rather than the spine (e.g., tumors, fibromyalgia, rheumatoid arthritis, gout)
✕. Patients with other chronic diseases that could interfere with the interpretation of treatment effects or outcomes (e.g., stroke, myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy)
✕. Patients currently taking steroids, immunosuppressants, psychiatric medications, or other drugs that could affect the study results
✕. Patients for whom pharmacopuncture treatment is inappropriate or unsafe: those with bleeding disorders, those undergoing anticoagulant therapy, and severe diabetic patients with infection risks
✕. Patients who have taken medications that could affect pain (e.g., Non-Steroidal Anti-Inflammatory Drugs, NSAIDs) or received pharmacopuncture, acupuncture, or physical therapy within the past week
✕. Pregnant women, those planning to become pregnant, or those currently breastfeeding